Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Adeno-associated viral vector serotype 9 containing the human iduronate-2-sulfatase gene

EU orphan designation number: EU/3/15/1540   
Active ingredient: Adeno-associated viral vector serotype 9 containing the human iduronate-2-sulfatase gene
Indication: Treatment of mucopolysaccharidosis type II (Hunter's syndrome)
Sponsor: Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109, 4th floor, 08038 Barcelona, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/08/2015 Orphan designation EMA/OD/076/15 (2015)5776 of 10/08/2015
5/09/2018 Change of name and/or address of sponsor